Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

5-O-(N-Boc-l-Alanine)-Renieramycin T Induces Cancer Stem Cell Apoptosis via Targeting Akt Signaling
Darinthip Suksamai, Satapat Racha, Nicharat Sriratanasak, et al.
Marine Drugs (2022) Vol. 20, Iss. 4, pp. 235-235
Open Access | Times Cited: 17

Showing 17 citing articles:

Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway
Sunisa Thongsom, Satapat Racha, Korrakod Petsri, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Novel Synthetic Derivative of Renieramycin T Right-Half Analog Induces Apoptosis and Inhibits Cancer Stem Cells via Targeting the Akt Signal in Lung Cancer Cells
Korrakod Petsri, Masashi Yokoya, Satapat Racha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5345-5345
Open Access | Times Cited: 8
Anticancer potential of active alkaloids and synthetic analogs derived from marine invertebrates
Chunyan Cai, Dejun Yang, Yi Cao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116850-116850
Closed Access | Times Cited: 3
Cisplatin Induces Senescent Lung Cancer Cell-Mediated Stemness Induction via GRP78/Akt-Dependent Mechanism
Nicharat Sriratanasak, Preedakorn Chunhacha, Zin Zin, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2703-2703
Open Access | Times Cited: 12
Shrimp Lipids Inhibit Migration, Epithelial–Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression
Chorpaka Thepthanee, Zin Zin, Soottawat Benjakul, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 722-722
Open Access | Times Cited: 2
Recent advances in the synthesis and activity of analogues of bistetrahydroisoquinoline alkaloids as antitumor agents
Ju Guo
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115917-115917
Closed Access | Times Cited: 5
Renieramycin T Inhibits Melanoma B16F10 Cell Metastasis and Invasion via Regulating Nrf2 and STAT3 Signaling Pathways
Baohua Yu, Jing Liang, Xiufang Li, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5337-5337
Open Access | Times Cited: 8
Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge Xestospongia sp., in Mediating Non-Small-Cell Lung Cancer Cell Apoptosis
Iksen Iksen, Suwimon Sinsook, Onsurang Wattanathamsan, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8948-8948
Open Access | Times Cited: 8
Simplified Synthesis of Renieramycin T Derivatives to Target Cancer Stem Cells via β-Catenin Proteasomal Degradation in Human Lung Cancer
Zin Zin, Satapat Racha, Masashi Yokoya, et al.
Marine Drugs (2023) Vol. 21, Iss. 12, pp. 627-627
Open Access | Times Cited: 3
Asymmetric synthesis of phthalascidin, zalypsis and renieramycin T from N-Cbz-L-tyrosine
Yue Wang, Junhao Jia, Qin Zhou, et al.
Tetrahedron (2023) Vol. 146, pp. 133624-133624
Closed Access | Times Cited: 2
Light-Mediated Transformation of Renieramycins and Semisynthesis of 4′-Pyridinecarbonyl-Substituted Renieramycin-Type Derivatives as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells
Suwimon Sinsook, Koonchira Buaban, Iksen Iksen, et al.
Marine Drugs (2023) Vol. 21, Iss. 7, pp. 400-400
Open Access | Times Cited: 1
Marine Natural Products as Anticancer Agents
Celso Alves, Marc Diederich
MDPI eBooks (2021)
Open Access | Times Cited: 1
Marine Natural Products as Anticancer Agents 2.0
Celso Alves, Marc Diederich
Marine Drugs (2023) Vol. 21, Iss. 4, pp. 247-247
Open Access
Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines
Koonchira Buaban, Bhurichaya Innets, Korrakod Petsri, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access
A novel MDM2-p53 antagonist APG115 exerts synergistic effect with ibrutinib via targeting MCL-1 in chronic lymphocytic leukemia
Yang Han, Xinting Hu, Hua Wang, et al.
Research Square (Research Square) (2022)
Open Access
Photochemical reaction of renieramycins and evaluation of cytotoxicity against lung cancer cells
Suwimon Sinsook
(2022)
Open Access
Renieramycin t derivative dh_22 induces apoptosis in lung cancer cells by downregulation of C-Myc protein
INDIANA GITA ANGGRAENI
(2022)
Open Access
Page 1

Scroll to top